Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer. Midatech Pharma PLC is collaborating with universities and pharmaceutical companies to develop its platform technologies into a range of products. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange LON
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolLON:MTPH
Previous Symbol
CUSIPN/A
Phone+44-1235-841575
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees70
Outstanding SharesN/A
Market Cap£0.00
OptionableNot Optionable
Midatech Pharma (LON:MTPH) Frequently Asked Questions
What is Midatech Pharma's stock symbol?
Midatech Pharma trades on the London Stock Exchange (LON) under the ticker symbol "MTPH."
How were Midatech Pharma's earnings last quarter?
Midatech Pharma PLC (LON:MTPH) announced its earnings results on Thursday, September, 28th. The company reported ($19.00) EPS for the quarter. The firm earned $3.02 million during the quarter. View Midatech Pharma's Earnings History.
Has Midatech Pharma been receiving favorable news coverage?
Media stories about MTPH stock have trended somewhat positive on Friday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Midatech Pharma earned a coverage optimism score of 1.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 8.0 out of 10, meaning that recent press coverage is very likely to have an impact on the company's share price in the next few days.
Who are some of Midatech Pharma's key competitors?
Some companies that are related to Midatech Pharma include 22nd Century Group (XXII), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Almirall (LBTSF), Altimmune (ALT), Ampio Pharmaceuticals (AMPE), Ampliphi Biosciences (APHB) and Antibe Therapeutics (ATE).
Who are Midatech Pharma's key executives?
Midatech Pharma's management team includes the folowing people:
- Mr. Nicholas John Robbins-Cherry, CFO, Company Sec. & Director (Age 49)
- Dr. Craig Richard Cook, CEO, COO & Director (Age 51)
- Mr. Rob Rainey FCA MBA MA, Head of Corp. Devel.
- Dr. Tim Sparey Ph.D., Chief Bus. Officer
- Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing
How do I buy shares of Midatech Pharma?
Shares of MTPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Midatech Pharma's stock price today?
One share of MTPH stock can currently be purchased for approximately GBX 12.
What is Midatech Pharma's official website?
How can I contact Midatech Pharma?
Midatech Pharma's mailing address is 65 Innovation Drive, Milton Park, ABINGDON, OX14 4RQ, United Kingdom. The company can be reached via phone at +44-1235-841575.
MarketBeat Community Rating for Midatech Pharma (LON MTPH)
MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma and other stocks. Vote "Outperform" if you believe MTPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
